LiveActive security incident?Get immediate response
CVE Record

CVE-2021-40375: Apperta Foundation OpenEyes 3.5.1 allows remote attackers to view the sensitive information of patients wit...

Apperta Foundation OpenEyes 3.5.1 allows remote attackers to view the sensitive information of patients without having the intended level of privilege. Despite OpenEyes returning a Forbidden error message, the contents of a patient's profile are still returned in the server response. This response can be read in an intercepting proxy or by viewing the page source. Sensitive information returned in responses includes patient PII and medication records or history.

UnknownCVSS not scoredNot KEV-listedUpdated
Glexia's TakeAutomated analysishigh

Security readout for executives and security teams

Plain-English summary

OpenEyes 3.5.1 could expose patient details to users who should be blocked. The page may show a Forbidden error, but the server response can still contain patient profile data, including PII and medication history. For a healthcare system, this is a serious confidentiality and regulatory exposure issue.

Executive priority

Prioritize quickly if OpenEyes 3.5.1 supports real patient workflows. The business impact is patient data disclosure, not system takeover, but PHI exposure can trigger legal, regulatory, and trust consequences. If version 3.5.1 is not present, priority drops substantially.

Technical view

The vulnerability is an access-control failure with incomplete response handling: unauthorized patient profile requests can receive a Forbidden indication while sensitive profile content remains in the response body. Sources identify OpenEyes 3.5.1 and describe exposure through response inspection, but do not provide CVSS, CWE, patch status, or broader affected-version data.

Likely exposure

Likely exposure is limited to Apperta Foundation OpenEyes 3.5.1 deployments based on the provided sources. Other versions are not confirmed. Risk is highest where OpenEyes is reachable by many authenticated users, exposed over remote access paths, or used for live patient records.

Exploitation context

The CVE describes remote attackers viewing patient information without intended privilege. CISA KEV is false in the bundle, and no cited source confirms active exploitation. Public reference material exists, but this assessment avoids exploit procedure details.

Researcher notes

Evidence is sparse: the CVE text names OpenEyes 3.5.1 and describes sensitive response-body disclosure despite Forbidden messaging. No CVSS, CWE, confirmed patch, or affected-version range is provided. Validate defensively and rely on vendor/project guidance for remediation specifics.

Mitigation direction

  • Check vendor and OpenEyes project guidance for fixed versions or advisories.
  • Inventory OpenEyes deployments and confirm whether version 3.5.1 is present.
  • Limit OpenEyes access to trusted networks and required clinical users.
  • Review role-based access controls for patient profile visibility.
  • Monitor for unusual patient profile access or repeated Forbidden responses.
  • Treat exposed patient data as a potential privacy incident if confirmed.

Validation and detection

  • Confirm the deployed OpenEyes version and any vendor-applied security updates.
  • Test in an authorized staging environment using least-privileged user roles.
  • Verify Forbidden patient profile responses do not include sensitive body content.
  • Review web server and application logs for unauthorized profile access attempts.
  • Document whether PII or medication history could be exposed.
  • Retest after any vendor update or access-control change.
Prepared
Confidence
medium
Sources
4

Generated from the cited source records. This long-tail analysis has not been individually reviewed by a named human.

Potential ATT&CK relevance

Conservative CVE-to-ATT&CK context

These mappings and lookup hints may be relevant to the vulnerability behavior, CWE, affected product, or exposure path. Glexia-inferred context is not an official MITRE, ATT&CK, CWE, or CVE Program mapping.

ATT&CK lookup starting points

Use these exact CWE pages and searches to review the Glexia ATT&CK library from this CVE's weakness and description context.

cve · low confidence lookup

CVE-2021-40375 mapping review

Open the CVE-to-ATT&CK bridge for reviewed, inferred, or future official mappings tied to this CVE.

Open ATT&CK lookup
Vulnerability profileCVE Program record
Severity
Unknown
CVSS
Not scored
Known Exploited
No
Published
Official CVE source material

CNA and ADP enrichment extracted from CVE v5

These fields come from the CVE record and ADP containers, not from Glexia's Take. They preserve time-varying source decisions such as CISA SSVC, KEV status, CVSS metrics, and provider references.

0CVSS vectors
0Timeline events
0ADP providers
3Source links

CVSS and timeline data

No CVSS vectors or timeline events were available in the normalized CVE source material.

Source materials

Affected products

Products and packages named in the record

VendorProductVersion / packageStatus
n/an/an/aListed
Weakness

CWE details

No CWE listed

CWE links open Glexia weakness intelligence pages with official CWE context, developer remediation guidance, and related CVE mappings.